Concepedia

Publication | Open Access

Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy

49

Citations

25

References

2016

Year

Abstract

Five independent prognostic factors in patients with recurrent or metastatic pancreatic cancer who received gemcitabine-based chemotherapy were identified. These findings may be helpful in prediction of prognosis in clinical practice and can be used as a stratification factor for clinical trials.

References

YearCitations

2015

27.2K

2010

11.5K

2011

7.6K

2013

6.5K

1997

5.8K

2007

3.8K

2002

3.1K

2013

2.5K

2008

2.1K

2015

1.2K

Page 1